If successful, they'll get the FDA to classify it as too complex to compound, blocking all compounding. Takes a year or so, so not immediate.
Also, I saw that Lilly is aiming to get Retatrutide labeled as a biological from the start, preventing compounding when it's released in '26.
It's all...